Identification of Functional Domains in Kaposica, the Complement Control Protein Homolog of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8)

ABSTRACT Recently it has been shown that kaposica, an immune evasion protein of Kaposi's sarcoma-associated herpesvirus, inactivates complement by acting on C3-convertases by accelerating their decay as well as by acting as a cofactor in factor I-mediated inactivation of their subunits C3b and C4b. Here, we have mapped the functional domains of kaposica. We show that SCRs 1 and 2 (SCRs 1-2) and 1-4 are essential for the classical and alternative pathway C3-convertase decay-accelerating activity (DAA), respectively, while the SCRs 2-3 are required for factor I cofactor activity (CFA) for C3b and C4b. SCR 3 and SCRs 1 and 4, however, contribute to optimal classical pathway DAA and C3b CFA, respectively. Binding data show that SCRs 1-4 and SCRs 1-2 are the smallest structural units required for measuring detectable binding to C3b and C4b, respectively. The heparin-binding site maps to SCR 1.

[1]  P. Lachmann Microbial subversion of the immune response , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Moore,et al.  Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? , 2003, Annual review of microbiology.

[3]  A. Namane,et al.  Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .

[4]  E. Cesarman,et al.  Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi ’ s Sarcoma – Associated Herpesvirus / Human Herpesvirus - , 1997 .

[5]  J. Volanakis The human complement system in health and disease , 1998 .

[6]  M. Pangburn,et al.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. , 1993, The Biochemical journal.

[7]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Schulz,et al.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 1998, The Journal of general virology.

[9]  M. Pangburn,et al.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. , 1993, The Biochemical journal.

[10]  S. Shchelkunov,et al.  Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense , 2000, Journal of Virology.

[11]  C. Mold,et al.  Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. , 1996, Journal of immunology.

[12]  D. Lublin,et al.  Identification of complement regulatory domains in human factor H. , 1995, Journal of immunology.

[13]  D. McCance Human Tumor Viruses , 1998 .

[14]  A. Blom,et al.  Structural Requirements for the Complement Regulatory Activities of C4BP* , 2001, The Journal of Biological Chemistry.

[15]  A. Blom,et al.  Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus* , 2003, The Journal of Biological Chemistry.

[16]  B. Levine,et al.  Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. , 2002, Immunity.

[17]  Robert B Sim,et al.  Interactions between human complement components factor H, factor I and C3b. , 1997, The Biochemical journal.

[18]  A. Sahu,et al.  Kinetic Analysis of the Interactions between Vaccinia Virus Complement Control Protein and Human Complement Proteins C3b and C4b , 2004, Journal of Virology.

[19]  D. Isenman,et al.  Identification of Residues within the 727–767 Segment of Human Complement Component C3 Important for Its Interaction with Factor H and with Complement Receptor 1 (CR1, CD35)* , 1999, The Journal of Biological Chemistry.

[20]  J. Lambris,et al.  Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Open Reading Frame 4 Protein (Kaposica) Is a Functional Homolog of Complement Control Proteins , 2003, Journal of Virology.

[21]  A. Alcamí,et al.  Viral mechanisms of immune evasion , 2000, Immunology Today.

[22]  G. McFadden,et al.  Poxviruses and immune evasion. , 2003, Annual review of immunology.

[23]  R. Means,et al.  Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. , 2002, Current topics in microbiology and immunology.

[24]  B. Moss,et al.  Regulation of complement activity by vaccinia virus complement-control protein. , 1992, The Journal of infectious diseases.

[25]  H. Ploegh,et al.  Virus subversion of immunity: a structural perspective. , 2001, Current opinion in immunology.

[26]  D. Hourcade,et al.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. , 2000, Immunopharmacology.

[27]  S. Meri,et al.  Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Therapeutic Interventions in the Complement System , 2000 .

[29]  N. Sherman,et al.  Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .

[30]  Q. Pan,et al.  Two Clusters of Acidic Amino Acids Near the NH2 Terminus of Complement Component C4 α′-Chain Are Important for C2 Binding1 , 2000, The Journal of Immunology.

[31]  D. Hourcade,et al.  Decay Accelerating Activity of Complement Receptor Type 1 (CD35) , 1999, The Journal of Biological Chemistry.

[32]  A. Sahu,et al.  Herpes and pox viral complement control proteins: 'the mask of self'. , 2003, Trends in immunology.

[33]  O. Spiller,et al.  Complement Regulation by Kaposi's Sarcoma-Associated Herpesvirus ORF4 Protein , 2003, Journal of Virology.

[34]  N. Cooper Complement and Viruses , 1998 .

[35]  T. Nagashunmugam,et al.  Viral interference with antibody and complement , 1998, Seminars in Cell & Developmental Biology.

[36]  John D Lambris,et al.  Complement Inhibitors Targeting C3, C4, and C5 , 2000 .

[37]  B. Morgan The Human Complement System in Health and Disease. , 1998 .